Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
69.34 USD | +0.13% | -3.32% | -8.41% |
Summary
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- With regards to fundamentals, the enterprise value to sales ratio is at 0.81 for the current period. Therefore, the company is undervalued.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-8.41% | 8.88B | B+ | ||
-3.78% | 1.39B | D | ||
-11.09% | 1.13B | - | ||
-20.27% | 837M | - | - | |
+0.43% | 451M | - | ||
+0.90% | 427M | - | - | |
-25.71% | 329M | - | - | |
-54.07% | 328M | - | ||
-4.60% | 207M | - | - | |
+2.92% | 193M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- HSIC Stock
- Ratings Henry Schein, Inc.